|Bid||0.77 x 0|
|Ask||0.79 x 0|
|Day's Range||0.75 - 0.79|
|52 Week Range||0.73 - 1.45|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.28|
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to provide an update on the product strategy of the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”), as well as a number of strategic additions to the management team of Dosecann. Dosecann, Auxly’s cornerstone midstream asset that is Canada’s largest cannabis specific “Licensed Dealer”, is positioned to play a significant role as a leading research, product development, extraction, formulation and consumer packaged goods manufacturing center in the Canadian cannabis industry with its 42,000 square foot purpose-built facility in Charlottetown, PEI. As previously announced, Dosecann has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada and has commenced operations related to the creation of value-added cannabis products, as permitted by the Licence and applicable laws.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that it has entered into a strategic partnership with Cannabis OneFive, Inc. (“C15”), a provider of quality management and document control software systems for the cannabis industry. Auxly’s wholly-owned subsidiary, Dosecann Inc. (“Dosecann”), will become a lead subscriber of C15’s software, and the Company expects the C15 software to be deployed at other Auxly facilities. In connection with the strategic partnership, the Company has entered into a share exchange agreement (the “Share Exchange Agreement”) with C15.
Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that the Company’s wholly-owned subsidiary, Dosecann Inc. (“Dosecann”), has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada pursuant to the Narcotics Control Regulations for Dosecann’s purpose built 42,000 square foot facility located in Charlottetown, PEI.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly"), is pleased to announce that its strategic down-stream retail partner Inner Spirit Holdings Ltd. ("Inner Spirit"), has received all of the necessary exchange and regulatory approvals to commence trading publicly on the Canadian Securities Exchange under the symbol “ISH” as of August 1, 2018. Pursuant to the requirements of National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and applicable Canadian securities legislation, Auxly announces that in connection with the completion by Inner Spirit of its initial public offering on July 31, 2018 (the "IPO"), Auxly has acquired 7,058,824 units of Inner Spirit, with each unit consisting of one common share of Inner Spirit (each a "Common Share") and one-half of one Common Share purchase warrant of Inner Spirit (for a total of 3,529,412 warrants) in consideration for an aggregate purchase price of $1,058,823.60, with each warrant entitling the holder to purchase one Common Share at an exercise price of $0.30 per Common Share for a period of 24 months from the date of issuance.
CALGARY, July 31, 2018 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or "the Company"), is pleased to announce that it has closed its initial public offering (the "IPO"). The Company closed on the maximum gross proceeds under the IPO of $3,750,000 and issued 25,000,000 units of Inner Spirit (the "Units"). Each Unit consists of one common share in the capital of the Company (each, a "Common Share") and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Unit Warrant").
CALGARY, July 30, 2018 /CNW/ - High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it has recently entered into multiple non-binding memorandums of understanding ("MOUs") to supply the Saskatchewan market on a wholesale basis for a combined total of up to 9,500 kilograms of cannabis products over the next year, as available. High Tide is in the process of becoming a licensed wholesaler of cannabis products in the province of Saskatchewan. The MOUs are with FV Pharma Inc. ("FV Pharma"), Maple Leaf Green World Inc. ("Maple Leaf"), Sundial Growers Inc. ("Sundial") and The Supreme Cannabis Company, Inc. ("Supreme").
VANCOUVER, British Columbia, July 27, 2018-- Auxly Cannabis Group Inc. is pleased to announce that it has received the approval of the TSX Venture Exchange for the listing of 32,200,000 common share purchase ...
Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that its wholly-owned subsidiary, Kolab Project Inc. ("Kolab" or “Kolab Project”), has received its sales licence from Health Canada, pursuant to the Access to Cannabis for Medical Purposes Regulations. Kolab will source the best cannabis products from the entire Auxly cultivation platform and through partnerships with acclaimed growers from around the world. Among these will be Kolab’s facility in Carleton Place, Ontario, where the second phase of construction has been completed and is expected to be commissioned for cultivation in the coming months.
CSE:HUGE OTC:FSDDF TORONTO , July 19, 2018 /CNW/ - FSD Pharma Inc. ("FSD Pharma") (CSE:HUGE) (OTC:FSDDF) today announced that its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma") ...
Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that Auxly’s streaming partner, CannTx Life Sciences Inc. (“CannTx”), has been granted a cultivation licence for its production facility in Puslinch, Ontario pursuant to the Access to Cannabis for Medical Purposes Regulations. Chuck Rifici, Chairman and CEO of Auxly commented, "We want to congratulate the team at CannTx on obtaining their cultivation licence! This represents a major milestone and achievement for CannTx and for the broader Auxly business strategy. Pursuant to the definitive agreement entered on December 22, 2017, the Company has provided CannTx with $5,000,000 related to the initial costs for the phase I construction of CannTx's 30,000 square foot facility.
Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") has announced today that following his appointment as Chief Executive Officer of a federal agency, Invest in Canada, Ian McKay has resigned as a director of the Company’s Board of Directors. The Company has initiated a search for a new director to replace Mr. McKay. Chuck Rifici, Chairman and Chief Executive Officer of Auxly Cannabis Group commented, “On behalf of the Board of Directors and the Auxly team, I'd like to thank Ian for his valuable guidance and support over the past year.
VANCOUVER, British Columbia, July 06, 2018-- Auxly Cannabis Group Inc. is pleased to announce that effective today, July 6, 2018, the Company's common shares on the OTC Markets will begin trading on the ...
TORONTO, July 3, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (CSE:HUGE.CN - News) is pleased to provide an update on the progress of the joint venture between its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma) and Auxly Cannabis Group Inc. (TSX.V – XLY) ("Auxly"). The first phase of the buildout of the FV Pharma facility (the "Facility") in Cobourg, Ontario has been approved in an updated construction and development budget provided by Auxly. Of the current 620,000 square feet of building space available, 220,000 square feet will be developed and fully funded.
Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to provide the following construction development update on the joint venture with FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of FSD Pharma Inc. (CSE:HUGE) at the former Kraft food-production facility (the “Facility”) located in Cobourg, Ontario. The Facility hosts an initial 620,000 square feet of building space, a portion of which is currently licensed for cultivation pursuant to the Access to Cannabis for Medical Purposes Regulations, and can support additional expansion capacity of approximately 3,800,000 square feet on the existing property, pending completion of all phases of the project. Pursuant to the updated and approved construction budget, Auxly will contribute $55,000,000 to develop the first phase of the project.
Auxly Cannabis Group Inc. (XLY.V) ("Auxly" or the "Company") is pleased to announce that further to its previously announced transaction on February 16, 2018, the Company has entered into a definitive joint venture agreement with Peter Quiring, one of Canada’s largest greenhouse builders and operators, via a newly formed subsidiary (the "JVCo"), to develop, construct and operate a fully-automated, state-of-the-art, purpose-built greenhouse for cannabis cultivation in Leamington, Ontario (the "Facility"). Pursuant to the agreement, Mr. Quiring, through South Essex Fabricating, will be responsible for the design, construction and operation of the Facility, and the Company will be responsible for funding the project and assisting JVCo in obtaining its ACMPR license for the cultivation and sale of cannabis (the “License”) by providing JVCo with all of the resources and expertise necessary to achieve the License.